Cipla is committed to transparency in financial relationships with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs).
Cipla is committed to compliance by disclosing our financial relationships as required by the Association of the British Pharmaceutical Industry (ABPI) Code of Practice.
Working with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs)
Cipla works with HCPs and HCOs to improve the development and delivery of our medicines for patients.
In line with current ABPI requirements, Cipla submits information regarding transfers of value made to HCPs and HCOs to the ABPI central disclosure platform. For further information, please visit
Patient Organisations
In line with the ABPI Code, Cipla is providing details of the Patient Organisations it partners with, including monetary and non-monetary support.
In 2023, Cipla did not provide any monetary or non-monetary support to UK Patient Organisations.
2022 support provided to UK Patient Organisations
Patient organisation | Description of activity or project support | Net value of support (£) |
---|---|---|
Asthma and Lung UK | Unrestricted donation | £1000 |